Condition: Cataract · Glaucoma · Ocular Hypertension · Sponsor: SpyGlass Pharma, Inc.
This trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.
This description comes directly from the study's public registry record.
Director, Clinical Affairs · 949-284-6904 · clinical@spyglasspharma.com
Always discuss trial participation with your own doctor first.
| Houston Eye Associates | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07218783